23andMe Teaming Up With Big Pharma To Sell Your DNA Data

Two ‘shady’ companies are getting together, a giant pharmaceutical company by the name of GlaxoSmithKline, and 23andme,  a privately held personal genomics and biotechnology company based in Mountain View, California. It’s a multi-billion dollar deal, and 23andMe will only collaborate with GSK on drug development projects for the duration of this deal. What does this mean? 23andMe has been collecting people’s DNA data and are now about to start selling it. And you’ll get none of those billions. Companies like GlaxoSmithKline, since their birth, have been developing harmful medications for years that kill at least 100,000 people a year in the United States alone. Countless lawsuits, injuries, deaths, and examples of scientific fraud on behalf of multiple pharmaceutical companies are extremely common. Yet they are still allowed to develop drugs and be trusted with public health. Here is a great example. The meta-analysis sourced in the article explains how many of the studies were falsified, and data from clinical trials were not disclosed by the pharmaceutical companies. (Read more)

---